Table 2:

Sub-hazard Ratios for MACE among CAC groups

	Statin vs No Statin*		> 50% compliance*
	aSHR (95% CI)	p value	aSHR (95% CI)	p value
CAC = 0	1.00 (0.79–1.27)	0.99	0.66 (0.49–0.88)	0.0046
CAC > 0	0.76 (0.60–0.95)	0.015	0.76 (0.59–0.98)	0.031
CAC 1–100	0.83 (0.60–1.16)	0.29	0.78 (0.53–1.15)	0.21
CAC 101–400	0.32 (0.21–0.48)	<0.0001	0.32 (0.20–0.51)	<0.0001
CAC 401+	0.56 (0.34–0.90)	0.017	0.59 (0.35–0.99)	0.044
CAC > 100 vs CAC < 100	0.46 (0.31–0.67)	<0.0001	0.61 (0.40–0.93)	0.021

Groups compared after IPTW and adjusting for competing hazard of non-cardiovascular death.

aSHR = adjusted subhazard ratio. CI=Confidence Interval.

^*Presence or absence of statin prescription within 5 years of CAC before MACE or end of follow-up.

^†>50% compliance with statin therapy during follow-up period vs patients with no statin exposure